長期投資家のためのIR情報
バリュートレンド

【4514】あすか製薬 〔上場廃止〕
ー(上場廃止)製薬。婦人科、泌尿器。
類似企業:
【業界1位】 小野薬品工業
【売上同水準】 扶桑薬品工業 栄研化学

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2021.03 2021/02/01 修正予 54,000 ↑ +1.9% +1.9% 2,800 ↑ +40.0% +40.0% 2,100 ↑ +10.5% +10.5% 1,900 ↑ +26.7% +26.7%
2021.03 2020/11/04 Q2予 53,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,900 → 0.0% 0.0% 1,500 → 0.0% 0.0%
2021.03 2020/08/03 Q1予 53,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 1,900 → 0.0% 0.0% 1,500 → 0.0% 0.0%
2021.03 2020/05/12 当初予 53,000 - - - 2,000 - - - 1,900 - - - 1,500 - - -
2020.03 2020/05/12 実 52,542 ↑ +0.1% -0.9% 1,507 ↓ -24.7% -24.7% 1,715 ↑ +0.9% -18.3% 649 ↑ +8.2% -35.1%
2020.03 2020/04/24 修正予 52,500 ↓ -0.9% -0.9% - - - - 1,700 ↓ -19.0% -19.0% 600 ↓ -40.0% -40.0%
2020.03 2020/02/03 Q3予 53,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,100 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2020.03 2019/11/05 Q2予 53,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,100 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2020.03 2019/08/05 Q1予 53,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,100 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2020.03 2019/05/10 当初予 53,000 - - - 2,000 - - - 2,100 - - - 1,000 - - -
2019.03 2019/05/10 実 46,706 ↓ -2.7% -4.7% 1,782 ↓ -10.9% +78.2% 1,980 ↓ -5.7% +65.0% 1,744 ↑ +9.0% +74.4%
2019.03 2019/02/04 修正予 48,000 ↓ -2.0% -2.0% 2,000 ↑ +100.0% +100.0% 2,100 ↑ +75.0% +75.0% 1,600 ↑ +60.0% +60.0%
2019.03 2018/11/05 Q2予 49,000 → 0.0% 0.0% 1,000 - - - 1,200 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2019.03 2018/05/11 当初予 49,000 - - - - - - - 1,200 - - - 1,000 - - -
2018.03 2018/05/11 実 - - - - - - - - - - - - - - - -
2018.03 2018/02/05 Q3予 50,000 → 0.0% 0.0% 3,000 ↑ +50.0% +50.0% 3,200 ↑ +52.4% +52.4% 2,600 ↑ +44.4% +44.4%
2018.03 2017/11/06 Q2予 50,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,100 → 0.0% 0.0% 1,800 → 0.0% 0.0%
2018.03 2017/08/07 Q1予 50,000 → 0.0% 0.0% 2,000 → 0.0% 0.0% 2,100 → 0.0% 0.0% 1,800 → 0.0% 0.0%
2018.03 2017/05/12 当初予 50,000 - - - 2,000 - - - 2,100 - - - 1,800 - - -
2017.03 2017/05/12 実 48,527 ↑ +1.1% +7.8% 1,793 ↑ +19.5% +79.3% 2,002 ↑ +17.8% +66.8% 2,944 ↑ +9.0% +194.4%
2017.03 2017/03/31 修正予 48,000 → 0.0% +6.7% 1,500 ↓ -16.7% +50.0% 1,700 ↓ -15.0% +41.7% 2,700 ↓ -25.0% +170.0%
2017.03 2017/02/06 Q3予 48,000 → 0.0% +6.7% 1,800 → 0.0% +80.0% 2,000 → 0.0% +66.7% 3,600 → 0.0% +260.0%
2017.03 2016/12/20 修正予 48,000 → 0.0% +6.7% 1,800 → 0.0% +80.0% 2,000 → 0.0% +66.7% 3,600 ↑ +111.8% +260.0%
2017.03 2016/11/07 Q2予 48,000 ↑ +6.7% +6.7% 1,800 ↑ +80.0% +80.0% 2,000 ↑ +66.7% +66.7% 1,700 ↑ +70.0% +70.0%
2017.03 2016/08/04 Q1予 45,000 → 0.0% 0.0% 1,000 → 0.0% 0.0% 1,200 → 0.0% 0.0% 1,000 → 0.0% 0.0%
2017.03 2016/05/12 当初予 45,000 - - - 1,000 - - - 1,200 - - - 1,000 - - -
2016.03 2016/05/12 実 43,215 ↑ +0.0% -8.1% 1,166 ↑ +0.5% -41.7% 1,522 ↑ +0.1% -30.8% 701 ↑ +0.1% -56.2%
2016.03 2016/04/25 修正予 43,210 ↓ -1.8% -8.1% 1,160 ↑ +45.0% -42.0% 1,520 ↑ +52.0% -30.9% 700 ↑ +16.7% -56.3%
2016.03 2016/02/04 Q3予 44,000 → 0.0% -6.4% 800 → 0.0% -60.0% 1,000 → 0.0% -54.5% 600 → 0.0% -62.5%
2016.03 2015/11/04 Q2予 44,000 ↓ -6.4% -6.4% 800 ↓ -60.0% -60.0% 1,000 ↓ -54.5% -54.5% 600 ↓ -62.5% -62.5%
2016.03 2015/08/03 Q1予 47,000 → 0.0% 0.0% 2,000 - - - 2,200 → 0.0% 0.0% 1,600 → 0.0% 0.0%
2016.03 2015/05/12 当初予 47,000 - - - - - - - 2,200 - - - 1,600 - - -
2015.03 2015/05/12 実 - - - - - - - - - - - - - - - -
2015.03 2015/02/04 Q3予 44,000 → 0.0% +2.3% 1,200 → 0.0% +20.0% 1,400 → 0.0% +7.7% 1,000 → 0.0% +25.0%
2015.03 2014/11/04 Q2予 44,000 ↑ +2.3% +2.3% 1,200 ↑ +20.0% +20.0% 1,400 ↑ +7.7% +7.7% 1,000 ↑ +25.0% +25.0%
2015.03 2014/08/04 Q1予 43,000 → 0.0% 0.0% 1,000 → 0.0% 0.0% 1,300 → 0.0% 0.0% 800 → 0.0% 0.0%
2015.03 2014/05/13 当初予 43,000 - - - 1,000 - - - 1,300 - - - 800 - - -
2014.03 2014/05/13 実 39,501 - - - 716 - - - 1,031 - - - 495 - - -
シェア ツイート
ページトップへ戻る